Amgen joining forces with ADC player Synaffix and agreeing to as high as $2 billion in Synaffix’s licensing deal.
Seem like deals are coming fast at Synaffix. Our DX-3 will be highly desirable and majority of big pharma inking licensing deal with us.
https://endpts.com/amgen-kicks-off-2023-dealmaking-with-busy-adc-upstart-synaffix/ View attachment 4955447
Amgen joining forces with ADC player Synaffix and agreeing to as...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.51M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 654316 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1586680 | 3 |
View Market Depth
| Last trade - 10.06am 08/05/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable